Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
March Added One Mega-Deal, and Saw Another One Halted
After a busy M&A month in February, with 125 deals reported, March didn’t disappoint. Preliminary results show deal volume equaled the previous month’s total. The figures look good, in the face of the recent stock market swings, the Trump administration’s talk of trade wars and cancelling trade deals. But a look back to March 2017 shows this month’s deal volume is down 19% compared with the 155 deals logged then. And that wase in the face of the Trump administration’s efforts to repeal and replace the Affordable Care Act. Check out the April issue of Health Care M&A News for the deal volume and value charts, by sector. We’re not saying this year’s healthcare market is lacking in... Read More »
Digital Health Deals Are Blooming
The eHealth sector is on a roll, and the momentum seems to be gaining every month. Deal volume in the first quarter of 2018, at 45 announced transactions, was 50% higher than in the fourth quarter of 2017. With only four deals fewer than the same quarter in 2017, the 8% dip in deal volume hardly counts as a sell-off. Deal values, which aren’t a solid measure of growth in mergers and acquisitions, were still impressive. In Q1:18, digital health transactions totalled approximately $3.9 billion, up 96% compared with the same quarter a year earlier. That puts the eHealth sector ahead of the Pharmaceuticals sector, which has endured at least 18 months of slow M&A activity. Pharma’s dollar... Read More »
Q1:18 Results: Healthcare Goes Retail
First, the easy news. Deal volume in the first quarter of 2018 was on par with the previous quarter’s total of 380 deals. Preliminary data show 378 transactions were announced in the first quarter, making for a decline of 1% that will likely be erased as more deal activity is uncovered. Compared with the first quarter in 2017, however, deal volume was down 14%, versus the 439 deals reported then. Deal value for the quarter is where the data deviates from previous norms. The first quarter in 2017 posted a very robust $59.6 billion in disclosed deal value. In the fourth quarter of the year, deal value leapt to nearly $115.0 billion, thanks largely to the $77 billion proposed acquisition of... Read More »
Health Care M&A Weekly Deals, The Week Ending March 30, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Biotechnology Acquirer Target Price Celgene Corporation Exclusive worldwide license to ABX-1772 N/A BioIVT Ascendance Biotechnology, Inc. N/A Roivant Sciences Exclusive license to lefamulin $5 million Hospitals Acquirer Target Price IK... Read More »
LLR Partners Builds Eye Health Platform
With three acquisitions made, Philadelphia, Pennsylvania-based LLR Partners has formed Eye Health America, a practice management services organization initially focused on eye care practices in the southeastern United States. The three founding practices are Clemson Eye in Clemson, South Carolina; The Eye Associates with six clinics in and around Bradenton, Florida; and Piedmont Surgery Center, an AAAHC-accredited ambulatory surgery center providing ophthalmology, pain and ENT services in Greenville, South Carolina. Financial terms were not disclosed. All will continue to operate under their current brands. Rod Roeser, an industry executive with more than 20 yeas of experience in the eye... Read More »
China’s iKang Healthcare Goes Private
iKang Healthcare Group, Inc. (NASDAQ: KANG) has posted a long string of acquisitions in recent years, as the Chinese healthcare company expanded its reach into that country’s largest cities. As of March 26, 2018, iKang owned and operated a network of 110 medical centers in 33 cities in China. iKang is one of China’s largest providers of private preventivie healthcare. Its customer base is comprised primarily of corporate clients who contract with iKang to deliver medical examination services to their employees and clients, and receive those services at pre-agreed rates. The company also directly markets its services to individual customers. At the end of 2017, iKang served a... Read More »
Cognizant Gets Bolder Healthcare Solutions
Cognizant Technology Solutions Corp. (NASDAQ: CTSH) has dabbled in eHealth acquisitions before. In March, the professional services company was back in the healthcare space targeting Bolder Healthcare Solutions, LLC for $108 million. Bolder Healthcare was formed in 2012 through a co-investment partnership between The Edgewater Funds and JZ Capital Partners, in coordination with senior industry leaders. The company offers a suite of healthcare revenue cycle management services to the Hospital and Physician Medical Group sectors. Since its founding, Bolder Healthcare has grown through acquisition. Two acquisitions in 2015 brought in Avectus Healthcare Solutions, which provides a... Read More »
Health Care M&A Weekly Deals, The Week Ending March 23, 2018
We hope you are enjoying your membership to HealthCareMandA.com. This Health Care M&A Weekly chart below is a selection of transactions announced during the prior week(s). The deals presented here are further elaborated in the monthly newsletter, Health Care M&A News, and in the quarterly report. This information also appears in our online database, Deal Search Online. Visit www.dealsearchonline.com to open a guest account and begin your search. Behavioral Health Care Acquirer Target Price Netcare Limited Akeso Clinics $108 million Biotechnology Acquirer Target Price UCB S.A. Exclusive license to inflammatory drug candidate N/A SYGNIS AG TGR Biosciences $7.98 million Knight... Read More »
Physician Practices Find Many Buyers
The first quarter of 2018 is nearly over (one week left to go), and the Physician Medical Group sector is still in acquisition mode. Last year, the first quarter saw a record 59 deals announced for physician groups. This year’s Q1 total won’t challenge that, but the 30 deals reported so far show interest isn’t waning for buyers or sellers. We’ve written extensively about private equity groups building platforms of specialty practices, particularly dermatology, anesthesia and ophthalmology. But publicly traded entities are still in the hunt. In the first three weeks of March 2018, 13 deals for physician practices were announced, although none disclosed financial... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
